MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, MEDP made $706,604K in revenue. $123,870K in net income. Net profit margin of 17.53%.

Income Overview

Revenue
$706,604K
Net Income
$123,870K
Net Profit Margin
17.53%
EPS
$4.28
Unit: Thousand (K) dollars
Revenue Breakdown
    • Metabolic
    • Oncology
    • Other
    • Others

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenue, net (includes 7.3 million and 13.8 million with related parties for the three months ended march31, 2026 and 2025, respectively)
706,604 655,962* 659,903 603,311
Direct Costs
198,274 173,887* 186,335 185,826
Reimbursable Out Of Pocket Costs
312,004 266,338* 276,629 237,472
Total direct costs
510,278 440,224* 462,964 423,298
Selling, general and administrative
47,917 55,440* 48,082 46,664
Depreciation
6,751 6,793* 6,813 6,777
Amortization
155 237* 236 237
Total operating expenses
565,101 502,693* 518,095 476,976
Income from operations
141,503 153,269 141,808 126,335
Miscellaneous income (expense), net
971 -158 -489 -2,875
Interest income, net
5,117 3,722 1,517 1,078
Total other income, net
6,088 3,564 1,028 -1,797
Income before income taxes
147,591 156,833 142,836 124,538
Income tax provision
23,721 21,700 31,701 34,278
Net income
123,870 135,133 111,135 90,260
Basic EPS
4.35 4.782 3.95 3.16
Diluted EPS
4.28 4.667 3.86 3.1
Basic Average Shares
28,445,000 28,260,000 28,136,000 28,601,000
Diluted Average Shares
28,962,000 28,952,000 28,817,000 29,143,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Metabolic$237,558K Oncology$201,239K Other$93,318K Central Nervous System$80,207K Cardiology$56,261K Antiviral And AntiInfective$38,021K Revenue, net (includes7.3 million and 13.8...$706,604K Interest income, net$5,117K (-20.83%↓ Y/Y)Miscellaneous income(expense), net$971K (153.47%↑ Y/Y)Income from operations$141,503K (24.65%↑ Y/Y)Total other income,net$6,088K (31.01%↑ Y/Y)Total operatingexpenses$565,101K Income before incometaxes$147,591K (24.90%↑ Y/Y)Total direct costs$510,278K Selling, general andadministrative$47,917K Depreciation$6,751K Amortization$155K Net income$123,870K (8.09%↑ Y/Y)Income tax provision$23,721K (563.52%↑ Y/Y)Reimbursable Out Of PocketCosts$312,004K Direct Costs$198,274K

Medpace Holdings, Inc. (MEDP)

Medpace Holdings, Inc. (MEDP)